AstraZeneca developed its vaccine in partnership with Oxford University (Image: GETTY)
So far, some 135,000 individuals in Norway have received their first dose against the disease and some 35,000 have received their second shot, from vaccines made by Moderna and from a partnership between Pfizer and BioNTech, the agency said.
The FHI said there had been few participants above the age of 65 in the trial conducted by AstraZeneca, meaning there was a lack of documentation as to the effect of the vaccine on older age groups.
Clement Beaune, France’s Minister for European Affairs, yesterday stirred up controversy after he claimed the UK was risking lives by not following suit.
Every COVID vaccine manufacturer passed on making them in Canada: federal procurement minister Procurement Minister Anita Anand announces a delay to COVID vaccine delivery via videoconference, Friday, January 15, 2021 in Ottawa. Photo by Adrian Wyld/The Canadian Press/File Procurement Minister Anita Anand said she tried to entice all of the COVID-19 vaccine manufacturers to make their product here at home, but Canada didn’t have the facilities they needed.
Speaking at the House of Commons industry committee, Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but Canada’s facilities were simply too small.
IN BRIEF: Beximco s Private Market Covid Vaccine Supply Delayed
Thu, 4th Feb 2021 14:51
Beximco Pharmaceuticals Ltd - Bangladesh-based generic pharmaceutical products and active pharmaceutical ingredients maker - Partner Serum Institute of India Pvt Ltd s supply to Beximco of a first instalment of the Oxford University and AstraZeneca PLC Covid-19 vaccine for the Bangladesh private pay market has been delayed. The delay is attributed to prioritisation on supplying vaccine doses for government mass vaccination programmes as well as World Health Organisation-led initiatives over private pay use. The length of this delay, which is for the first 500,000 doses of a 1 million dose deal is not yet known, Beximco says.
Manila [Philippines], Feburary 3 (ANI/Xinhua): The Department of Health (DOH) of the Philippines reported on Wednesday 1,266 new confirmed cases of COVID-19, bringing the Southeast Asian country s total tally to 530,118.
The death toll rose to 10,942 after 68 more patients died from the coronavirus epidemic, the DOH said. It added that 130 more patients recovered, raising the total number of recoveries to 487,721.
The Philippines, which has about 110 million population, has tested over 7.4 million people since the viral disease emerged in January last year.
Carlito Galvez, the National Task Force against COVID-19 chief implementer, told a virtual press conference that the Philippine government plans to administer the first batch of 117,000 doses of COVID-19 vaccines from the World Health Organization-led COVAX facility to around 56,000 healthcare workers in four government COVID-19 hospitals in Metro Manila.
Philippines logs 1,266 COVID-19 cases, total tops 530,000 ANI | Updated: Feb 03, 2021 15:57 IST
Manila [Philippines], Feburary 3 (ANI/Xinhua): The Department of Health (DOH) of the Philippines reported on Wednesday 1,266 new confirmed cases of COVID-19, bringing the Southeast Asian country s total tally to 530,118.
The death toll rose to 10,942 after 68 more patients died from the coronavirus epidemic, the DOH said. It added that 130 more patients recovered, raising the total number of recoveries to 487,721.
The Philippines, which has about 110 million population, has tested over 7.4 million people since the viral disease emerged in January last year.
Carlito Galvez, the National Task Force against COVID-19 chief implementer, told a virtual press conference that the Philippine government plans to administer the first batch of 117,000 doses of COVID-19 vaccines from the World Health Organization-led COVAX facility to around 56,000 healthcare